VideoCategory: Molecular targets

Star icon

Molecular targets research are specific molecules within cells that interact with drugs or other compounds to influence biological processes, making them vital for understanding disease mechanisms and developing effective therapies. This category focuses on research exploring these targets, such as proteins or nucleic acids implicated in cancer and other conditions, grounded in the broader field of oncology and carcinogenesis. JoVE Visualize uniquely enriches this research by pairing PubMed articles with JoVE’s experiment videos, offering researchers and students a clearer view of the experimental methods and scientific findings behind key molecular targets.

Key Methods & Emerging Trends

Core Methods in Molecular Target Research

Established techniques in studying molecular targets include high-throughput screening to identify drug interactions, X-ray crystallography and cryo-electron microscopy for structural analysis, and molecular cloning combined with gene editing tools like CRISPR for functional validation. Biochemical assays and imaging methods are also widely used to characterize target molecules and their interactions within cancer cells. These methods help clarify molecular mechanisms essential to targeted cancer therapies and drug development efforts.

Emerging Techniques Shaping the Field

Innovative approaches are advancing molecular target research, such as single-cell sequencing and spatial transcriptomics, which reveal heterogeneity in tumor environments and target expression. AI-driven drug target prediction platforms, including adaptations of the Molecular Targets Platform focusing on pediatric oncology data, accelerate the discovery of novel targets. Integrative omics and real-time molecular imaging are increasingly employed to monitor drug-target interactions dynamically, improving translational potential from laboratory discoveries to clinical applications.

Research

Fields in

VideoCategory: Molecular targets

Recently Published Articles

July 1, 1979

|

Neuropharmacology

Abolition of oxotremorine effects by L-DOPA pretreatment

  • A D Korczyn, Y Eshel et al.

November 13, 2015

|

Hormone Molecular Biology and Clinical Investigation

Suppressor of cytokine signaling 2 (SOCS2) deletion protects against multiple low dose streptozotocin-induced type 1 diabetes in adult male mice

  • Amira Alkharusi, Mercedes Mirecki-Garrido, Zuheng Ma et al.

November 14, 2015

|

Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type

  • Petar Jelinic, Brooke A Schlappe, Niamh Conlon et al.

December 26, 2015

|

BMC Cancer

Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation

  • Cristina Grange, Marta Tapparo, Stefania Tritta et al.

January 23, 2016

|

Molecular Pharmaceutics

Bacterial Effector Nanoparticles as Breast Cancer Therapeutics

  • Lina Herrera Estrada, Trudy J Padmore, Julie A Champion et al.